跳至主要内容
临床试验/JPRN-UMIN000002351
JPRN-UMIN000002351已完成未知

Effect of Cilostazol compared with Clopidogrel about prevention of myocardial injury after elective percutaneous coronary intervention :Prospective,Randomized,Open,Blinded-Endpoint trial - ECARTE trial

Department of Cardiology, Nagoya University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2010年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Patients with unstable angina (2)Patients who use drug-eluting stents (DES) (3)Patients with a medical history of acute myocardial infarction within three months (4)Patients whose levels of CK and CK-MB,troponin-I are above upper limits of normal at the time of consent acquisition (5)Patients taking an anticoagulant (warfarin) (6)Patients who have a medical history of hypersensitivity to cilostazol, aspirin, and/or clopidogrel (7)Patients with thrombocytopenia (8)Patients with hepatic dysfunction (AST (GOT) or ALT(GPT) > 100 IU/L within three months) (9)Patients with renal dysfunction (serum creatinine >2.0mg/dl within three months) (10)Patients with congestive heart failure (11)Patients who are pregnant (12)Patients with bleeding

研究者

发起方
Department of Cardiology, Nagoya University Graduate School of Medicine

相似试验